Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/risk-of-hospitalization-for-cardiovascular-events-with-blockers-in-TacbTbANuF
References (34)
-
(2016)
Bystolic Ò (nebivolol tablets) -
L. Brewster, Y. Seedat (2013)
Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic reviewBMC Medicine, 11
-
C. Mende, T. Giles, D. Bharucha, W. Ferguson, M. Mallick, Mehul Patel (2017)
Efficacy of nebivolol‐valsartan single‐pill combination in obese and nonobese patients with hypertensionJournal of Clinical Hypertension (Greenwich, Conn.), 19
-
C. Vlachopoulos, K. Aznaouridis, M. O'Rourke, M. Safar, K. Baou, C. Stefanadis (2010)
Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis.European heart journal, 31 15
-
M. Paz, Alejandro de-La-Sierra, M. Sáez, M. Barceló, J. Rodriguez, S. Castro, Cristina Lagarón, J. Garrido, Pilar Vera, Gabriel Coll-de-Tuero (2016)
Treatment efficacy of anti-hypertensive drugs in monotherapy or combinationMedicine, 95
-
C. Thomopoulos, G. Parati, A. Zanchetti (2015)
Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs – Overview and meta-analysesJournal of Hypertension, 33
-
E. Saunders, W. Smith, K. Desalvo, W. Sullivan (2007)
The Efficacy and Tolerability of Nebivolol in Hypertensive African American PatientsThe Journal of Clinical Hypertension, 9
-
P. Studinger, Á. Tabák, Chen-Huan Chen, P. Salvi, T. Othmane, P. Torzsa, J. Kapocsi, B. Fekete, A. Tislér (2013)
The Effect of Low‐Dose Carvedilol, Nebivolol, and Metoprolol on Central Arterial Pressure and Its Determinants: A Randomized Clinical TrialThe Journal of Clinical Hypertension, 15
-
J. Redón, Jose Pascual-Izuel, E. Rodilla, A. Vicente, J. Oliván, J. Bonet, Josep Torguet, O. Calaforra, J. Almirall (2014)
Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: A multicenter, randomized, double-blind studyBlood Pressure, 23
-
Justin Fongemie, Erika Felix-Getzik (2015)
A Review of Nebivolol Pharmacology and Clinical EvidenceDrugs, 75
-
T. Münzel, T. Gori (2009)
Nebivolol: the somewhat-different beta-adrenergic receptor blocker.Journal of the American College of Cardiology, 54 16
-
D. Mozaffarian, E. Benjamin, A. Go, D. Arnett, M. Blaha, M. Cushman, Sandeep Das, S. Ferranti, J. Despres, H. Fullerton, V. Howard, Mark Huffman, C. Isasi, M. Jimenez, S. Judd, B. Kissela, J. Lichtman, L. Lisabeth, Simin Liu, R. Mackey, D. Magid, Darren Mcguire, E. Mohler, C. Moy, P. Muntner, M. Mussolino, K. Nasir, R. Neumar, G. Nichol, L. Palaniappan, D. Pandey, M. Reeves, C. Rodriguez, W. Rosamond, P. Sorlie, J. Stein, A. Towfighi, T. Turan, S. Virani, D. Woo, R. Yeh, M. Turner (2016)
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart AssociationCirculation, 133
-
B. Dahlöf, P. Sever, N. Poulter, H. Wedel, D. Beevers, M. Caulfield, R. Collins, S. Kjeldsen, A. Kristinsson, G. Mcinnes, J. Mehlsen, M. Nieminen, E. O’Brien, J. Östergren (2005)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled triThe Lancet, 366
-
P. James, S. Oparil, B. Carter, W. Cushman, C. Dennison-Himmelfarb, J. Handler, D. Lackland, M. LeFevre, T. Mackenzie, O. Ogedegbe, Sidney Smith, L. Svetkey, S. Taler, R. Townsend, J. Wright, A. Narva, E. Ortiz (2014)
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).JAMA, 311 5
-
M. Pedersen, J. Cockcroft (2007)
The vasodilatory beta-blockersCurrent Hypertension Reports, 9
-
(Tenormin® (atenolol tablets). US prescribing information. Wilmington: AstraZeneca Pharmaceuticals LP. 2011.)
Tenormin® (atenolol tablets). US prescribing information. Wilmington: AstraZeneca Pharmaceuticals LP. 2011.Tenormin® (atenolol tablets). US prescribing information. Wilmington: AstraZeneca Pharmaceuticals LP. 2011., Tenormin® (atenolol tablets). US prescribing information. Wilmington: AstraZeneca Pharmaceuticals LP. 2011.
-
T. Giles, B. Khan, June Lato, L. Brener, Yimin Ma, T. Lukić (2013)
Nebivolol Monotherapy in Younger Adults (Younger Than 55 Years) With Hypertension: A Randomized, Placebo‐Controlled TrialThe Journal of Clinical Hypertension, 15
-
C. Wiysonge, H. Bradley, J. Volmink, B. Mayosi, A. Mbewu, L. Opie (2012)
Beta-blockers for hypertension.The Cochrane database of systematic reviews, 8
-
(2010)
Combination therapy in hypertensionJ Am Soc Hypertens., 4
-
P. Kampus, M. Serg, J. Kals, M. Zagura, P. Muda, K. Karu, M. Zilmer, J. Eha (2011)
Differential Effects of Nebivolol and Metoprolol on Central Aortic Pressure and Left Ventricular Wall ThicknessHypertension, 57
-
A. Gradman, J. Basile, B. Carter, G. Bakris, B. Materson, Henry Black, Joseph Izzo, S. Oparil, Michael Weber (2010)
Combination therapy in hypertension.Journal of the American Society of Hypertension : JASH, 4 2
-
B. Dahlöf, R. Devereux, S. Kjeldsen, S. Julius, G. Beevers, U. Faire, F. Fyhrquist, H. Ibsen, Krister Kristiansson, O. Lederballe‐Pedersen, L. Lindholm, M. Nieminen, P. Omvik, S. Oparil, H. Wedel (2002)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 359
-
R. Deyo, D. Cherkin, D. Cherkin, M. Ciol (1992)
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.Journal of clinical epidemiology, 45 6
-
(Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2012;11:Cd002003.)
Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2012;11:Cd002003.Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2012;11:Cd002003., Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2012;11:Cd002003.
-
(Bystolic® (nebivolol tablets). US prescribing information. Cincinnati: Forest Pharmaceuticals, Inc. 2016.)
Bystolic® (nebivolol tablets). US prescribing information. Cincinnati: Forest Pharmaceuticals, Inc. 2016.Bystolic® (nebivolol tablets). US prescribing information. Cincinnati: Forest Pharmaceuticals, Inc. 2016., Bystolic® (nebivolol tablets). US prescribing information. Cincinnati: Forest Pharmaceuticals, Inc. 2016.
-
M. Charlson, P. Pompei, Kathy Ales, C. MacKenzie (1987)
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.Journal of chronic diseases, 40 5
-
L. Lindholm, B. Carlberg, O. Samuelsson (2005)
Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysisThe Lancet, 366
-
H. Punzi, A. Lewin, T. Lukić, T. Goodin, Wei Chen (2010)
Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trialTherapeutic Advances in Cardiovascular Disease, 4
-
L. Bortel, F. Fıcı, Flavio Mascagni (2008)
Efficacy and Tolerability of Nebivolol Compared with Other Antihypertensive DrugsAmerican Journal of Cardiovascular Drugs, 8
-
(2008)
Lopressor Ò (metoprolol tartrate tablets). US prescribing information. East Hanover: Novartis Pharmaceuticals Corporation -
Zacharias Fj (1973)
Beta blockers in hypertension.Bruxelles medical, Spec No 0
-
M. Law, J. Morris, N. Wald (2009)
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesThe BMJ, 338
-
B. Materson (2007)
Variability in response to antihypertensive drugs.The American journal of medicine, 120 4 Suppl 1
-
O. Kamp, G. Sieswerda, C. Visser (2003)
Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension.The American journal of cardiology, 92 3
- Publisher
- Springer Journals
- Copyright
- Copyright © 2018 by The Author(s)
- Subject
- Medicine & Public Health; Internal Medicine; Cardiology
- ISSN
- 2193-8261
- eISSN
- 2193-6544
- DOI
- 10.1007/s40119-018-0117-y
- Publisher site
- See Article on Publisher Site
Abstract
Cardiol Ther (2018) 7:173–183 https://doi.org/10.1007/s40119-018-0117-y ORIGINAL RESEARCH Risk of Hospitalization for Cardiovascular Events with b-Blockers in Hypertensive Patients: A Retrospective Cohort Study . . . . Jan Basile Brent Egan Henry Punzi Sanjida Ali . . Qian Li Mehul Patel Joel Neutel Received: April 27, 2018 / Published online: September 6, 2018 The Author(s) 2018 to unfavorable long-term cardiovascular events ABSTRACT observed with non-vasodilatory b-blockers. However, the comparative cardiovascular event Introduction: b-Blockers are a heterogenous risk between the vasodilatory b -selective class of drugs that are no longer recommended antagonist/b agonist nebivolol and non-va- for initial antihypertension monotherapy due sodilatory b -blockers, atenolol and metoprolol, is unknown. Enhanced digital features To view enhanced digital Methods: Incident nebivolol, atenolol, or features for this article go to https://doi.org/10.6084/ m9.figshare.6965000. metoprolol monotherapy users with hyperten- sion were identified using US claims data Electronic supplementary material The online (2007–2014). The first b-blocker claim on/after version of this article (https://doi.org/10.1007/s40119- 018-0117-y) contains supplementary material, which is 1/1/2008 defined the index drug/date. Hyper- available to authorized users. tensive patients without pre-index cardiovas- cular history were followed until index drug J. Basile (&) discontinuation ([ 90 day supply gap), use of Medical University of South Carolina,
Journal
Cardiology and Therapy – Springer Journals
Published: Sep 6, 2018